Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2010

01-12-2010 | Epidemiology

Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients

Authors: E. Bastiaannet, G. J. Liefers, A. J. M. de Craen, P. J. K. Kuppen, W. van de Water, J. E. A. Portielje, L. G. M. van der Geest, M. L. G. Janssen-Heijnen, O. M. Dekkers, C. J. H. van de Velde, R. G. J. Westendorp

Published in: Breast Cancer Research and Treatment | Issue 3/2010

Login to get access

Abstract

Breast cancer is the most common type of cancer in several parts of the world and the number of elderly patients is increasing. The aim of this study was to describe stage at diagnosis, treatment, and relative survival of elderly patients compared to younger patients in the Netherlands. Adult female patients with their first primary breast cancer diagnosed between 1995 and 2005 were selected. Stage, treatment, and relative survival were described for young and elderly (≥65 years) patients and within the cohort of elderly patients according to 5-year age groups. Overall, 127,805 patients were included. Elderly breast cancer patients were diagnosed with a higher stage of disease. Moreover, within the elderly differences in stage were observed. Elderly underwent less surgery (99.2–41.2%); elderly received hormonal treatment as monotherapy more frequently (0.8–47.3%); and less adjuvant systemic treatment (79–53%). Elderly breast cancer patients with breast cancer had a decreased relative survival. Although relative survival was lower in the elderly, the percentage of patients who die of their breast cancer less than 50% above age 75. In conclusion, the relative survival for the elderly is lower as compared to their younger counterparts while the percentage of deaths due to other causes increases with age. This could indicate that the patient selection is poor and fit patients could suffer from “under treatment”. In the future, specific geriatric screening tools are necessary to identify fit elderly patients who could receive more “aggressive” treatment while best supportive care should be given to frail elderly patients.
Literature
1.
Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C et al (2007) Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8(12):1101–1115CrossRefPubMed
2.
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581–592CrossRefPubMed
3.
Louwman WJ, Vulto JC, Verhoeven RH, Nieuwenhuijzen GA, Coebergh JW, Voogd AC (2007) Clinical epidemiology of breast cancer in the elderly. Eur J Cancer 43(15):2242–2252CrossRefPubMed
4.
Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G (2007) Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 25(14):1858–1869CrossRefPubMed
5.
Houterman S, Janssen-Heijnen ML, Verheij CD, Louwman WJ, Vreugdenhil G, van der Sangen MJ et al (2004) Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 90(12):2332–2337PubMed
6.
Gennari R, Audisio RA (2008) Breast cancer in elderly women. Optimizing the treatment. Breast Cancer Res Treat 110(2):199–209CrossRefPubMed
7.
von EE, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457CrossRef
8.
Papanikolaou PN, Christidi GD, Ioannidis JP (2006) Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. Can Med Assoc J 174(5):635–641CrossRef
9.
Vandenbroucke JP (2004) When are observational studies as credible as randomised trials? Lancet 363(9422):1728–1731CrossRefPubMed
10.
Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA et al (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41(5):779–785CrossRefPubMed
11.
Lavelle K, Moran A, Howell A, Bundred N, Campbell M, Todd C (2007) Older women with operable breast cancer are less likely to have surgery. Br J Surg 94(10):1209–1215CrossRefPubMed
12.
Kurtz JE, Heitz D, Kurtz-Illig V, Dufour P (2009) Geriatric oncology: how far have we gone and what are the next steps? Oncology 77(3–4):147–156CrossRefPubMed
13.
14.
Hind D, Wyld L, Reed MW (2007) Surgery, with or without tamoxifen, vs. tamoxifen alone for older women with operable breast cancer: cochrane review. Br J Cancer 96(7):1025–1029CrossRefPubMed
15.
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106PubMed
16.
Truong PT, Bernstein V, Lesperance M, Speers CH, Olivotto IA (2006) Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 191(6):749–755CrossRefPubMed
17.
Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351(10):971–977CrossRefPubMed
18.
Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P et al (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12(7):997–1003CrossRefPubMed
19.
Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG (2006) Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98(10):681–690CrossRefPubMed
20.
Aziz D, Gardner S, Pritchard K, Paszat L, Holloway CM (2007) Selective application of axillary node dissection in elderly women with early breast cancer. Ann Surg Oncol 14(2):652–659CrossRefPubMed
21.
Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML (2005) Breast cancer treatment guidelines in older women. J Clin Oncol 23(4):783–791CrossRefPubMed
22.
Pinquart M, Duberstein PR (2004) Information needs and decision-making processes in older cancer patients. Crit Rev Oncol Hematol 51(1):69–80CrossRefPubMed
23.
Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55(3):231–240CrossRefPubMed
24.
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB et al (2009) Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 360(20):2055–2065CrossRefPubMed
Metadata
Title
Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients
Authors
E. Bastiaannet
G. J. Liefers
A. J. M. de Craen
P. J. K. Kuppen
W. van de Water
J. E. A. Portielje
L. G. M. van der Geest
M. L. G. Janssen-Heijnen
O. M. Dekkers
C. J. H. van de Velde
R. G. J. Westendorp
Publication date
01-12-2010
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0898-8

Other articles of this Issue 3/2010

Breast Cancer Research and Treatment 3/2010 Go to the issue

Clinical trial

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival

Preclinical study

Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study

Epidemiology

A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer

Letter to the Editor

Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: convergence and divergence of the two recent meta-analyses

Epidemiology

Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network

Epidemiology

BRCA1/2 test results impact risk management attitudes, intentions, and uptake
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits